# Cousins Properties Inc: financial statements, quarterly

CUZ · NYSE · CIK 25232 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cuz.md) · [Financials](/companies/cuz/financials.md) · [Filings](/companies/cuz/filings.md) · [Insiders](/companies/cuz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cuz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [199](/filings/0000025232-24-000057.md) | [197 d](/filings/0000025232-26-000014.md) | [209](/filings/0000025232-25-000029.md) | [213](/filings/0000025232-25-000045.md) | [209](/filings/0000025232-25-000061.md) | [225 d](/filings/0000025232-26-000014.md) | [250](/filings/0000025232-26-000044.md) | [240](/filings/0000025232-26-000063.md) | [248](/filings/0000025232-25-000061.md) | [255 d](/filings/0000025232-26-000014.md) | [263](/filings/0000025232-26-000044.md) | [269](/filings/0000025232-26-000063.md) |
| Cost of revenue | $m | [64.8](/filings/0000025232-24-000057.md) | [63.3 d](/filings/0000025232-26-000014.md) | [71.1](/filings/0000025232-25-000029.md) | [70.6](/filings/0000025232-25-000045.md) | [66.0](/filings/0000025232-25-000061.md) | [72.9 d](/filings/0000025232-26-000014.md) | [77.2](/filings/0000025232-26-000044.md) | [74.2](/filings/0000025232-26-000063.md) | [80.0](/filings/0000025232-25-000061.md) | [83.1 d](/filings/0000025232-26-000014.md) | [82.6](/filings/0000025232-26-000044.md) | [84.7](/filings/0000025232-26-000063.md) |
| Operating income | $m | [135](/filings/0000025232-24-000057.md) | [134 d](/filings/0000025232-26-000014.md) | [139](/filings/0000025232-25-000029.md) | [141](/filings/0000025232-25-000045.md) | [142](/filings/0000025232-25-000061.md) | [148 d](/filings/0000025232-26-000014.md) | [165](/filings/0000025232-26-000044.md) | [167](/filings/0000025232-26-000063.md) | [169](/filings/0000025232-25-000061.md) | [172 d](/filings/0000025232-26-000014.md) | [180](/filings/0000025232-26-000044.md) | [182](/filings/0000025232-26-000063.md) |
| Interest expense | $m | [27.0](/filings/0000025232-24-000057.md) | [27.5 d](/filings/0000025232-26-000014.md) | [28.9](/filings/0000025232-25-000029.md) | [29.7](/filings/0000025232-25-000045.md) | [30.8](/filings/0000025232-25-000061.md) | [33.1 d](/filings/0000025232-26-000014.md) | [36.8](/filings/0000025232-26-000044.md) | [38.5](/filings/0000025232-26-000063.md) | [41.5](/filings/0000025232-25-000061.md) | [42.5 d](/filings/0000025232-26-000014.md) | [45.1](/filings/0000025232-26-000044.md) | [47.1](/filings/0000025232-26-000063.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [19.4](/filings/0000025232-24-000057.md) | [18.8 d](/filings/0000025232-26-000014.md) | [13.3](/filings/0000025232-25-000029.md) | [7.8](/filings/0000025232-25-000045.md) | [11.2](/filings/0000025232-25-000061.md) | [13.6 d](/filings/0000025232-26-000014.md) | [20.9](/filings/0000025232-26-000044.md) | [14.5](/filings/0000025232-26-000063.md) | [8.6](/filings/0000025232-25-000061.md) | [(3.5) d](/filings/0000025232-26-000014.md) | [(24.9)](/filings/0000025232-26-000044.md) | [26.2](/filings/0000025232-26-000063.md) |
| Diluted EPS | $ per share | [0.13](/filings/0000025232-24-000057.md) | not reported | [0.09](/filings/0000025232-25-000029.md) | [0.05](/filings/0000025232-25-000045.md) | [0.07](/filings/0000025232-25-000061.md) | not reported | [0.12](/filings/0000025232-26-000044.md) | [0.09](/filings/0000025232-26-000063.md) | [0.05](/filings/0000025232-25-000061.md) | not reported | [(0.15)](/filings/0000025232-26-000044.md) | [0.16](/filings/0000025232-26-000063.md) |
| Basic EPS | $ per share | [0.13](/filings/0000025232-24-000057.md) | not reported | [0.09](/filings/0000025232-25-000029.md) | [0.05](/filings/0000025232-25-000045.md) | [0.07](/filings/0000025232-25-000061.md) | not reported | [0.12](/filings/0000025232-26-000044.md) | [0.09](/filings/0000025232-26-000063.md) | [0.05](/filings/0000025232-25-000061.md) | not reported | [(0.15)](/filings/0000025232-26-000044.md) | [0.16](/filings/0000025232-26-000063.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.9](/filings/0000025232-23-000059.md) | [6.0](/filings/0000025232-25-000012.md) | [5.5](/filings/0000025232-24-000024.md) | [6.0](/filings/0000025232-24-000044.md) | [76.1](/filings/0000025232-24-000057.md) | [7.3](/filings/0000025232-26-000014.md) | [5.3](/filings/0000025232-25-000029.md) | [417](/filings/0000025232-25-000045.md) | [4.7](/filings/0000025232-25-000061.md) | [5.7](/filings/0000025232-26-000063.md) | [6.3](/filings/0000025232-26-000044.md) | [6.7](/filings/0000025232-26-000063.md) |
| Total assets | $m | [7,585](/filings/0000025232-23-000059.md) | [7,634](/filings/0000025232-25-000012.md) | [7,683](/filings/0000025232-24-000024.md) | [7,701](/filings/0000025232-24-000044.md) | [7,771](/filings/0000025232-24-000057.md) | [8,802](/filings/0000025232-26-000014.md) | [8,663](/filings/0000025232-25-000029.md) | [9,052](/filings/0000025232-25-000045.md) | [8,900](/filings/0000025232-25-000061.md) | [8,890](/filings/0000025232-26-000063.md) | [9,088](/filings/0000025232-26-000044.md) | [9,041](/filings/0000025232-26-000063.md) |
| Total liabilities | $m | [3,008](/filings/0000025232-23-000059.md) | [3,086](/filings/0000025232-25-000012.md) | [3,168](/filings/0000025232-24-000024.md) | [3,223](/filings/0000025232-24-000044.md) | [3,331](/filings/0000025232-24-000057.md) | [3,932](/filings/0000025232-26-000014.md) | [3,826](/filings/0000025232-25-000029.md) | [4,251](/filings/0000025232-25-000045.md) | [4,143](/filings/0000025232-25-000061.md) | [4,188](/filings/0000025232-26-000063.md) | [4,555](/filings/0000025232-26-000044.md) | [4,549](/filings/0000025232-26-000063.md) |
| Long-term debt | $m | [2,418](/filings/0000025232-23-000059.md) | [2,458](/filings/0000025232-25-000012.md) | [2,563](/filings/0000025232-24-000024.md) | [2,587](/filings/0000025232-24-000044.md) | [2,661](/filings/0000025232-24-000057.md) | [3,096](/filings/0000025232-26-000014.md) | [3,021](/filings/0000025232-25-000029.md) | [3,477](/filings/0000025232-25-000045.md) | [3,309](/filings/0000025232-25-000061.md) | [3,341](/filings/0000025232-26-000063.md) | [3,772](/filings/0000025232-26-000044.md) | [3,732](/filings/0000025232-26-000063.md) |
| Shareholders' equity | $m | [4,555](/filings/0000025232-23-000059.md) | [4,524](/filings/0000025232-25-000012.md) | [4,491](/filings/0000025232-24-000024.md) | [4,454](/filings/0000025232-24-000044.md) | [4,416](/filings/0000025232-24-000057.md) | [4,847](/filings/0000025232-26-000014.md) | [4,814](/filings/0000025232-25-000029.md) | [4,778](/filings/0000025232-25-000045.md) | [4,735](/filings/0000025232-25-000061.md) | [4,680](/filings/0000025232-26-000063.md) | [4,511](/filings/0000025232-26-000044.md) | [4,484](/filings/0000025232-26-000063.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [116 d](/filings/0000025232-24-000057.md) | [90.8 d](/filings/0000025232-26-000014.md) | [28.3](/filings/0000025232-25-000029.md) | [126 d](/filings/0000025232-25-000045.md) | [117 d](/filings/0000025232-25-000061.md) | [129 d](/filings/0000025232-26-000014.md) | [44.8](/filings/0000025232-26-000044.md) | [123 d](/filings/0000025232-26-000063.md) | [120 d](/filings/0000025232-25-000061.md) | [114 d](/filings/0000025232-26-000014.md) | [40.5](/filings/0000025232-26-000044.md) | [157 d](/filings/0000025232-26-000063.md) |
| Dividends paid | $m | [48.6 d](/filings/0000025232-24-000057.md) | [48.5 d](/filings/0000025232-26-000014.md) | [48.6](/filings/0000025232-25-000029.md) | [49.5 d](/filings/0000025232-25-000045.md) | [48.7 d](/filings/0000025232-25-000061.md) | [48.7 d](/filings/0000025232-26-000014.md) | [54.6](/filings/0000025232-26-000044.md) | [53.7 d](/filings/0000025232-26-000063.md) | [53.8 d](/filings/0000025232-25-000061.md) | [53.7 d](/filings/0000025232-26-000014.md) | [55.3](/filings/0000025232-26-000044.md) | [52.7 d](/filings/0000025232-26-000063.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [152](/filings/0000025232-23-000059.md) | [152](/filings/0000025232-24-000024.md) | [152](/filings/0000025232-24-000044.md) | [152](/filings/0000025232-24-000057.md) | [152](/filings/0000025232-25-000029.md) | [153](/filings/0000025232-25-000045.md) | [153](/filings/0000025232-25-000061.md) | [169](/filings/0000025232-26-000044.md) | [169](/filings/0000025232-26-000063.md) | [169](/filings/0000025232-25-000061.md) | [166](/filings/0000025232-26-000044.md) | [165](/filings/0000025232-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 164,602,058 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0000025232-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.